TruTrace Technologies (CSE: TTT) has signed a definitive alliance with Applied DNA Sciences (NASDAQ: APDN) to develop a comprehensive cannabis product validation platform. Combining TruTrace’s StrainSecure™ with Applied DNA’s CertainT® system enables enhanced product authentication and end-to-end traceability through blockchain and molecular tagging. The agreement facilitates mutual referrals and technology integration, enhancing the security of cannabis supply chains. Notably, Shoppers Drug Mart employs TruTrace's platform for its medical cannabis program, underscoring its industry relevance.
Applied DNA Sciences (NASDAQ: APDN) and TruTrace Technologies (CSE: TTT) have formed a strategic alliance to implement a blockchain-based solution for the cannabis industry. The agreement integrates Applied DNA’s CertainT platform with TruTrace’s StrainSecure™ platform, enhancing product validation and authentication. This collaboration aims to ensure end-to-end traceability and transparency, offering significant advantages to consumers and brands against counterfeiting. The partnership also establishes a mutual referral system to capitalize on joint opportunities.
TruTrace Technologies (CSE: TTT; OTCQB: TTTSF) has appointed Allan O'Dette as Chairman and Pradeep Sood as Director to its Board of Directors. Allan brings over 30 years of experience, notably serving as CEO of the Ontario Medical Association and as the first Chief Investment Officer for Ontario. Pradeep has over 40 years of operations experience across multiple continents. CEO Robert Galarza highlighted their expertise in guiding organizations as instrumental for TruTrace's growth in supply chain transparency in the cannabis, food, and pharmaceutical industries.